Physician profile
Igor Dukarevich
NPI 1538326426
$1,194.46
in general payments reported to CMS, 2019-2025
15 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $27.38 · 2021: $146 · 2022: $105 · 2023: $285 · 2024: $235 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $333.81 | 2019-2025 | Grafix Pl, Pico 7, Acticoat 4" X 4" |
| Organogenesis INC. | $245.82 | 2022-2023 | Puraply |
| Next Science LLC | $167.31 | 2023-2024 | Surgx, Xperience, Blastx |
| Mimedx Group, INC. | $94.65 | 2024-2025 | |
| Depuy Synthes Sales INC. | $79.39 | 2021-2023 | Na |
| Stryker Corporation | $73.60 | 2021 | |
| Kerecis Limited | $43.40 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bioventus LLC | $30.00 | 2025 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $27.38 | 2020 | |
| Osiris Therapeutics INC. | $23.60 | 2019 | |
| Ets Wound Care LLC | $22.67 | 2023 | |
| Horizon Therapeutics Plc | $15.56 | 2022 | |
| Abbvie INC. | $14.59 | 2024 | |
| Zimmer Biomet Holdings, INC. | $11.43 | 2019 | |
| Convatec INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Dukarevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.